This site uesd JavaScript.
TOP
>
News Release
> list in 2005
Back Number
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others
2005.12.22
Daiichi Defeats Mylan in Dispute Over $1 Billion Per Year Drug Patent
HTML
PDF
2005.12.14
Transfer of a Portion of Sankyo Pharma GmbH Products
HTML
PDF
2005.12.06
Third Sankyo Takamine Memorial Award Granted
HTML
PDF
2005.12.05
Joint Research in Genome-based Target Discovery between Daiichi Pharmaceutical Co., Ltd. and Celestar Lexico-Sciences, Inc. has concluded
HTML
PDF
2005.11.25
Establishment of the Healthcare Company
DAIICHI SANKYO HEALTHCARE CO., LTD.
HTML
PDF
2005.11.17
Large Scale Clinical Trial MEGA Study* Employing the Hyperlipidemia Drug Mevalotin®
HTML
PDF
2005.11.04
DISCONTINUATION OF MARKETING ALLIANCE FOR KETOLIDE ANTIBIOTICS, "KETEKR® TABLETS 300MG"
HTML
PDF
2005.10.28
Announcement of Revised Results Forecasts of the Sub-subsidiary Wakodo Co., Ltd.
HTML
PDF
2005.10.26
Discontinuation of Clinical Studies of CS-505
(Pactimibe; Sankyo's ACAT Inhibitor)
HTML
PDF
2005.10.17
Report concerning revisions to the forecasted results of our sub-subsidiary company (Fuji Flour Milling Co., Ltd.)
HTML
PDF
2005.10.12
Completion of the Registration of Trial Subjects for ORIENT on the Suppressive Effects of the Angiotensin II Receptor Blocker Olmetec® against the Progression of Diabetic Nephropathy
HTML
PDF
2005.10.07
European Mutual Certification Completed for Antihypertensive
Olmetec Combination Drug
HTML
PDF
2005.09.28
Establishment of DAIICHI SANKYO COMPANY, LIMITED
HTML
PDF
Back Number
2010
2009
2008
2007
2006
2005
Browse by Category
Corporate
R&D
Products
Others